Related Experiment Video
Updated: Jan 24, 2026
06:05
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
1.6K
[Infantile haemangioma: an update].
1Klinik für Dermatologie und Venerologie, Universitätsklinikum Freiburg, Hauptstr. 7, 79104, Freiburg, Deutschland. antonia.reimer@uniklinik-freiburg.de.
Summary
Infantile haemangiomas (IH) are common childhood skin tumors. Complicated cases require prompt treatment, with propranolol being the preferred therapy to prevent lasting damage.
Area of Science:
- Pediatric Dermatology
- Oncology
- Vascular Malformations
Background:
- Infantile haemangioma (IH) represents the most prevalent skin tumor in pediatric populations.
- Diagnosis is typically achieved through clinical examination and observation of the characteristic growth pattern.
- Imaging is reserved for specific cases, such as segmental or facial IH.
Purpose of the Study:
- To outline the diagnostic and therapeutic approach for infantile haemangiomas.
- To emphasize the importance of timely intervention in complicated IH cases.
- To highlight the primary treatment modality for complicated IH.
Main Methods:
- Clinical assessment and diagnostic criteria for IH.
- Indications for sectional imaging in specific IH presentations.
- Review of treatment strategies for uncomplicated and complicated IH.
Main Results:
- Most IH are uncomplicated and do not necessitate treatment.
- Complicated IH require early intervention to mitigate potential permanent sequelae.
- Propranolol is identified as the first-line treatment for complicated IH.
Conclusions:
- Early diagnosis and management are crucial for IH.
- Prompt treatment of complicated IH with propranolol can prevent long-term complications.
- A conservative approach is suitable for the majority of IH cases.
